United States Pharmaceuticals

Track

Marinus Pharmaceuticals Inc (MRNS)

Track

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: MRNS Exchange: NMS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Ezickson Elan

1 sale — total 864 USD

Planned sale 21 Jan 2025

Value US$4,377,067.77 | Price 226.31 | Shares 3,116

Johnson Marvin

1 sale — total 869 USD

Planned sale 21 Jan 2025

Value US$3,459,338.40 | Price 358.33 | Shares 59,625

Saraswathy Nochur

Director

1 sale — total 3,743 USD

Proposed sale 10 Dec 2024

Value US$3,743.01 | Price 0.28 | Shares 13,250

Braunstein Scott

CHAIRMAN AND CEO

1 purchase — total 6,526 USD

Planned buy 14 Aug 2024

Value US$6,526.30 | Price 1.10 | Shares 5,933

Braunstein Scott

CHAIRMAN AND CEO

1 sale — total 13,724 USD

Planned sale 5 Aug 2024

Value US$13,723.85 | Price 1.13 | Shares 12,145

Hulihan Joseph

CHIEF MEDICAL OFFICER

1 sale — total 5,456 USD

Planned sale 5 Aug 2024

Value US$5,455.64 | Price 1.13 | Shares 4,828

MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

1 sale — total 4,092 USD

Planned sale 5 Aug 2024

Value US$4,091.73 | Price 1.13 | Shares 3,621

Shafer Christina

CHIEF COMMERCIAL OFFICER

1 sale — total 4,355 USD

Planned sale 5 Aug 2024

Value US$4,354.80 | Price 1.14 | Shares 3,820

Pfanstiel Steven

CFO AND COO

1 sale — total 5,262 USD

Planned sale 5 Aug 2024

Value US$5,262.41 | Price 1.13 | Shares 4,657

MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

1 sale — total 18,126 USD

Planned sale 20 Feb 2024

Value US$18,125.58 | Price 9.57 | Shares 1,894

Shafer Christina

CHIEF COMMERCIAL OFFICER

1 sale — total 20,583 USD

Planned sale 20 Feb 2024

Value US$20,582.68 | Price 9.56 | Shares 2,153

Pfanstiel Steven

CFO AND COO

1 sale — total 30,827 USD

Planned sale 16 Feb 2024

Value US$30,827.24 | Price 9.97 | Shares 3,092

Hulihan Joseph

CHIEF MEDICAL OFFICER

1 sale — total 28,084 USD

Planned sale 16 Feb 2024

Value US$28,083.72 | Price 9.98 | Shares 2,814

Braunstein Scott

CHAIRMAN AND CEO

1 sale — total 117,789 USD

Planned sale 16 Feb 2024

Value US$117,789.00 | Price 9.94 | Shares 11,850

Shafer Christina

CHIEF COMMERCIAL OFFICER

1 sale — total 98 USD

Planned sale 8 Aug 2023

Value US$98.23 | Price 8.93 | Shares 11

Braunstein Scott

CHAIRMAN AND CEO

1 sale — total 268 USD

Planned sale 8 Aug 2023

Value US$268.20 | Price 8.94 | Shares 30

Pfanstiel Steven

CFO AND COO

1 sale — total 125 USD

Planned sale 8 Aug 2023

Value US$125.02 | Price 8.93 | Shares 14

Hulihan Joseph

CHIEF MEDICAL OFFICER

1 sale — total 116 USD

Planned sale 8 Aug 2023

Value US$116.09 | Price 8.93 | Shares 13

MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

1 sale — total 98 USD

Planned sale 8 Aug 2023

Value US$98.23 | Price 8.93 | Shares 11

Shafer Christina

CHIEF COMMERCIAL OFFICER

1 sale — total 22,705 USD

Planned sale 7 Aug 2023

Value US$22,705.20 | Price 9.52 | Shares 2,385

Braunstein Scott

CHAIRMAN AND CEO

1 sale — total 61,244 USD

Planned sale 7 Aug 2023

Value US$61,244.15 | Price 9.55 | Shares 6,413

Pfanstiel Steven

CFO AND COO

1 sale — total 26,617 USD

Planned sale 7 Aug 2023

Value US$26,616.60 | Price 9.54 | Shares 2,790

Hulihan Joseph

CHIEF MEDICAL OFFICER

1 sale — total 27,590 USD

Planned sale 7 Aug 2023

Value US$27,589.95 | Price 9.55 | Shares 2,889

MANNING MARTHA E

SVP, GEN. COUNSEL & CORP. SEC.

1 sale — total 20,692 USD

Planned sale 7 Aug 2023

Value US$20,692.26 | Price 9.54 | Shares 2,169

Fischer Seth H. Z.

1 sale — total 6,658 USD

Planned sale 6 Feb 2023

Value US$6,657.72 | Price 6.54 | Shares 1,018

Ezickson Elan

1 sale — total 4,920 USD

Planned sale 6 Feb 2023

Value US$4,920.00 | Price 6.56 | Shares 750

Austin Charles

1 sale — total 6,964 USD

Planned sale 6 Feb 2023

Value US$6,963.77 | Price 6.49 | Shares 1,073

VITULLO NICOLE

1 sale — total 67,448 USD

Sale 15 Mar 2021

Value US$67,447.50 | Price 15.87 | Shares 4,250

Smith Edward F

Former VP, CFO & Treasurer

1 sale — total 718,337 USD

Planned sale 9 Mar 2021

Value US$718,336.80 | Price 17.80 | Shares 40,356

Smith Edward F

CFO

1 sale — total 4,879 USD

Sale 30 Jan 2020

Value US$4,879.00 | Price 2.05 | Shares 2,380

Braunstein Scott

Chief Executive Officer

1 purchase — total 125,000 USD

Buy 13 Dec 2019

Value US$125,000.00 | Price 1.25 | Shares 100,000

Smith Edward F

CFO

1 sale — total 121,781 USD

Planned sale 16 May 2019

Value US$121,781.33 | Price 5.03 | Shares 24,211

Smith Edward F

CFO

1 sale — total 7,626 USD

Sale 29 Jan 2019

Value US$7,625.52 | Price 3.06 | Shares 2,492

Cashman Christopher Michael

CEO

1 sale — total 25,484 USD

Sale 28 Jan 2019

Value US$25,484.46 | Price 3.13 | Shares 8,142

Smith Edward F

CFO

1 sale — total 23,730 USD

Sale 29 Jan 2018

Value US$23,730.00 | Price 7.91 | Shares 3,000

Cashman Christopher Michael

CEO

1 sale — total 60,074 USD

Sale 18 Jan 2018

Value US$60,074.48 | Price 6.28 | Shares 9,566

Bain Capital Life Sciences Investors, LLC

2 sales — total 1,114,670 USD

Sale 19 Dec 2017

Value US$392,429.66 | Price 7.11 | Shares 55,229

Sale 19 Dec 2017

Value US$722,240.31 | Price 7.62 | Shares 94,771

Bain Capital Life Sciences Investors, LLC

1 sale — total 2,251,440 USD

Sale 18 Dec 2017

Value US$2,251,440.00 | Price 7.50 | Shares 300,000

Bain Capital Life Sciences Investors, LLC

2 sales — total 6,658,691 USD

Sale 15 Dec 2017

Value US$888,488.95 | Price 8.64 | Shares 102,882

Sale 15 Dec 2017

Value US$5,770,202.00 | Price 8.02 | Shares 719,665

Mehra Anand

3 sales — total 1,042,699 USD

Sale 20 Oct 2016

Value US$17,401.39 | Price 1.39 | Shares 12,528

Sale 20 Oct 2016

Value US$18,566.76 | Price 1.39 | Shares 13,367

Sale 20 Oct 2016

Value US$1,006,730.53 | Price 1.39 | Shares 724,788

Canaan VII LP

1 sale — total 29,925 USD

Sale 8 Aug 2016

Value US$29,925.00 | Price 1.50 | Shares 19,950

Canaan VII LP

1 sale — total 193,806 USD

Sale 5 Aug 2016

Value US$193,806.00 | Price 1.50 | Shares 129,204

Canaan VII LP

1 sale — total 4,994 USD

Sale 4 Aug 2016

Value US$4,993.50 | Price 1.50 | Shares 3,329

Canaan VII LP

1 sale — total 213,381 USD

Sale 3 Aug 2016

Value US$213,381.00 | Price 1.50 | Shares 142,254

Canaan VII LP

1 sale — total 41,963 USD

Sale 29 Jul 2016

Value US$41,963.40 | Price 1.71 | Shares 24,540

Canaan VII LP

1 sale — total 376 USD

Sale 27 Jul 2016

Value US$376.20 | Price 1.80 | Shares 209

Canaan VII LP

1 sale — total 36,888 USD

Sale 26 Jul 2016

Value US$36,887.80 | Price 1.81 | Shares 20,380

Canaan VII LP

1 sale — total 255,968 USD

Sale 25 Jul 2016

Value US$255,967.62 | Price 1.86 | Shares 137,617

Canaan VII LP

1 sale — total 258,278 USD

Sale 22 Jul 2016

Value US$258,278.02 | Price 1.94 | Shares 133,133

Cashman Christopher Michael

President and CEO

1 purchase — total 19,977 USD

Buy 6 Nov 2015

Value US$19,977.21 | Price 5.61 | Shares 3,561

Farfel Gail M

Chief Clinical Dev & Reg Offic

1 sale — total 284,511 USD

Planned sale 21 Apr 2015

Value US$284,511.00 | Price 9.48 | Shares 30,000

Mehra Anand

3 purchases — total 6,005,464 USD

Buy 5 Aug 2014

Value US$100,224.00 | Price 8.00 | Shares 12,528

Buy 5 Aug 2014

Value US$106,936.00 | Price 8.00 | Shares 13,367

Buy 5 Aug 2014

Value US$5,798,304.00 | Price 8.00 | Shares 724,788

Domain Partners VI, L.P.

1 purchase — total 3,357,952 USD

Buy 5 Aug 2014

Value US$3,357,952.00 | Price 8.00 | Shares 419,744

Bloch Stephen M

1 purchase — total 5,000,000 USD

Buy 5 Aug 2014

Value US$5,000,000.00 | Price 8.00 | Shares 625,000

Canaan VII L P

1 purchase — total 5,000,000 USD

Buy 5 Aug 2014

Value US$5,000,000.00 | Price 8.00 | Shares 625,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-01-23	2025-01-21	PlS Planned sale	Ezickson Elan Non-Executive Director	3,116 -7.0% 226.31 US$4,377,068	3,116 -7.0%	226.31	US$4,377,068
2025-01-23	2025-01-21	PlS Planned sale	Johnson Marvin Non-Executive Director	59,625 +44.6% 358.33 US$3,459,338	59,625 +44.6%	358.33	US$3,459,338
2024-12-10	2024-12-10	PrS Proposed sale	Saraswathy Nochur Director Non-Executive Director	9,916 193.11 US$3,171,946	9,916	193.11	US$3,171,946
2025-02-11	2024-08-14	PP Planned purchase	Braunstein Scott CHAIRMAN AND CEO Executive Director	5,933 +2.0% 1.10 US$6,526	5,933 +2.0%	1.10	US$6,526
2024-08-07	2024-08-05	PlS Planned sale	Braunstein Scott CHAIRMAN AND CEO Executive Director	12,145 -3.9% 1.13 US$13,724	12,145 -3.9%	1.13	US$13,724
2024-08-07	2024-08-05	PlS Planned sale	Hulihan Joseph CHIEF MEDICAL OFFICER Officer	4,828 -6.2% 1.13 US$5,456	4,828 -6.2%	1.13	US$5,456
2024-08-07	2024-08-05	PlS Planned sale	MANNING MARTHA E SVP, GEN. COUNSEL & CORP. SEC. Officer	3,621 -5.7% 1.13 US$4,092	3,621 -5.7%	1.13	US$4,092
2024-08-07	2024-08-05	PlS Planned sale	Shafer Christina CHIEF COMMERCIAL OFFICER Officer	3,820 -5.4% 1.14 US$4,355	3,820 -5.4%	1.14	US$4,355
2024-08-07	2024-08-05	PlS Planned sale	Pfanstiel Steven CFO AND COO Officer	4,657 -5.5% 1.13 US$5,262	4,657 -5.5%	1.13	US$5,262
2024-02-22	2024-02-20	PlS Planned sale	MANNING MARTHA E SVP, GEN. COUNSEL & CORP. SEC. Officer	1,894 -3.5% 9.57 US$18,126	1,894 -3.5%	9.57	US$18,126
2024-02-22	2024-02-20	PlS Planned sale	Shafer Christina CHIEF COMMERCIAL OFFICER Officer	2,153 -3.4% 9.56 US$20,583	2,153 -3.4%	9.56	US$20,583
2024-02-21	2024-02-16	PlS Planned sale	Pfanstiel Steven CFO AND COO Officer	3,092 -4.1% 9.97 US$30,827	3,092 -4.1%	9.97	US$30,827
2024-02-21	2024-02-16	PlS Planned sale	Hulihan Joseph CHIEF MEDICAL OFFICER Officer	2,814 -4.1% 9.98 US$28,084	2,814 -4.1%	9.98	US$28,084
2024-02-21	2024-02-16	PlS Planned sale	Braunstein Scott CHAIRMAN AND CEO Executive Director	11,850 -5.0% 9.94 US$117,789	11,850 -5.0%	9.94	US$117,789
2023-08-08	2023-08-08	PlS Planned sale	Shafer Christina CHIEF COMMERCIAL OFFICER Officer	11 -0.0% 8.93 US$98	11 -0.0%	8.93	US$98
2023-08-08	2023-08-08	PlS Planned sale	Braunstein Scott CHAIRMAN AND CEO Executive Director	30 -0.0% 8.94 US$268	30 -0.0%	8.94	US$268
2023-08-08	2023-08-08	PlS Planned sale	Pfanstiel Steven CFO AND COO Officer	14 -0.0% 8.93 US$125	14 -0.0%	8.93	US$125
2023-08-08	2023-08-08	PlS Planned sale	Hulihan Joseph CHIEF MEDICAL OFFICER Officer	13 -0.0% 8.93 US$116	13 -0.0%	8.93	US$116
2023-08-08	2023-08-08	PlS Planned sale	MANNING MARTHA E SVP, GEN. COUNSEL & CORP. SEC. Officer	11 -0.0% 8.93 US$98	11 -0.0%	8.93	US$98
2023-08-08	2023-08-07	PlS Planned sale	Shafer Christina CHIEF COMMERCIAL OFFICER Officer	2,385 -5.5% 9.52 US$22,705	2,385 -5.5%	9.52	US$22,705
2023-08-08	2023-08-07	PlS Planned sale	Braunstein Scott CHAIRMAN AND CEO Executive Director	6,413 -3.8% 9.55 US$61,244	6,413 -3.8%	9.55	US$61,244
2023-08-08	2023-08-07	PlS Planned sale	Pfanstiel Steven CFO AND COO Officer	2,790 -5.4% 9.54 US$26,617	2,790 -5.4%	9.54	US$26,617
2023-08-08	2023-08-07	PlS Planned sale	Hulihan Joseph CHIEF MEDICAL OFFICER Officer	2,889 -5.7% 9.55 US$27,590	2,889 -5.7%	9.55	US$27,590
2023-08-08	2023-08-07	PlS Planned sale	MANNING MARTHA E SVP, GEN. COUNSEL & CORP. SEC. Officer	2,169 -6.2% 9.54 US$20,692	2,169 -6.2%	9.54	US$20,692
2023-02-08	2023-02-06	PlS Planned sale	Fischer Seth H. Z. Non-Executive Director	1,018 -14.5% 6.54 US$6,658	1,018 -14.5%	6.54	US$6,658
2023-02-08	2023-02-06	PlS Planned sale	Ezickson Elan Non-Executive Director	750 -11.8% 6.56 US$4,920	750 -11.8%	6.56	US$4,920
2023-02-08	2023-02-06	PlS Planned sale	Austin Charles Non-Executive Director	1,073 -16.9% 6.49 US$6,964	1,073 -16.9%	6.49	US$6,964
2021-03-16	2021-03-15	S Sale	2.6 VITULLO NICOLE Non-Executive Director	4,250 -100.0% 15.87 US$67,448	4,250 -100.0%	15.87	US$67,448
2021-03-11	2021-03-09	PlS Planned sale	1.1 Smith Edward F Former VP, CFO & Treasurer Officer	40,356 -75.2% 17.80 US$718,337	40,356 -75.2%	17.80	US$718,337
2020-02-03	2020-01-30	S Sale	1.1 Smith Edward F CFO	2,380 -11.8% 2.05 US$4,879	2,380 -11.8%	2.05	US$4,879
2019-12-13	2019-12-13	B Purchase	Braunstein Scott Chief Executive Officer Executive Director	100,000 +inf% 1.25 US$125,000	100,000 +inf%	1.25	US$125,000
2019-05-20	2019-05-16	PlS Planned sale	1.1 Smith Edward F CFO Officer	24,211 -54.6% 5.03 US$121,781	24,211 -54.6%	5.03	US$121,781
2019-01-30	2019-01-29	S Sale	1.1 Smith Edward F CFO Officer	2,492 -5.3% 3.06 US$7,626	2,492 -5.3%	3.06	US$7,626
2019-01-30	2019-01-28	S Sale	0.5 Cashman Christopher Michael CEO Executive Director	8,142 -3.3% 3.13 US$25,484	8,142 -3.3%	3.13	US$25,484
2018-01-29	2018-01-29	S Sale	Smith Edward F CFO Officer	3,000 -5.7% 7.91 US$23,730	3,000 -5.7%	7.91	US$23,730
2018-01-22	2018-01-18	S Sale	Cashman Christopher Michael CEO Executive Director	9,566 -3.7% 6.28 US$60,074	9,566 -3.7%	6.28	US$60,074
2017-12-19	2017-12-19	S Sale	Bain Capital Life Sciences Investors, LLC Large shareholder	55,229 -1.4% 7.11 US$392,430	55,229 -1.4%	7.11	US$392,430
2017-12-19	2017-12-19	S Sale	Bain Capital Life Sciences Investors, LLC Large shareholder	94,771 -2.3% 7.62 US$722,240	94,771 -2.3%	7.62	US$722,240
2017-12-19	2017-12-18	S Sale	Bain Capital Life Sciences Investors, LLC Large shareholder	300,000 -6.8% 7.50 US$2,251,440	300,000 -6.8%	7.50	US$2,251,440
2017-12-19	2017-12-15	S Sale	Bain Capital Life Sciences Investors, LLC Large shareholder	102,882 -2.3% 8.64 US$888,489	102,882 -2.3%	8.64	US$888,489
2017-12-19	2017-12-15	S Sale	Bain Capital Life Sciences Investors, LLC Large shareholder	719,665 -13.7% 8.02 US$5,770,202	719,665 -13.7%	8.02	US$5,770,202
2016-10-24	2016-10-20	S Sale	1.6 Mehra Anand Large shareholder	12,528 -44.7% 1.39 US$17,401	12,528 -44.7%	1.39	US$17,401
2016-10-24	2016-10-20	S Sale	1.6 Mehra Anand Large shareholder	13,367 -5.6% 1.39 US$18,567	13,367 -5.6%	1.39	US$18,567
2016-10-24	2016-10-20	S Sale	1.6 Mehra Anand Large shareholder	724,788 -39.0% 1.39 US$1,006,731	724,788 -39.0%	1.39	US$1,006,731
2016-08-09	2016-08-08	S Sale	Canaan VII LP Large shareholder	19,950 -1.1% 1.50 US$29,925	19,950 -1.1%	1.50	US$29,925
2016-08-09	2016-08-05	S Sale	Canaan VII LP Large shareholder	129,204 -6.5% 1.50 US$193,806	129,204 -6.5%	1.50	US$193,806
2016-08-05	2016-08-04	S Sale	Canaan VII LP Large shareholder	3,329 -0.2% 1.50 US$4,994	3,329 -0.2%	1.50	US$4,994
2016-08-05	2016-08-03	S Sale	Canaan VII LP Large shareholder	142,254 -6.6% 1.50 US$213,381	142,254 -6.6%	1.50	US$213,381
2016-08-02	2016-07-29	S Sale	Canaan VII LP Large shareholder	24,540 -1.1% 1.71 US$41,963	24,540 -1.1%	1.71	US$41,963
2016-07-27	2016-07-27	S Sale	Canaan VII LP Large shareholder	209 -0.0% 1.80 US$376	209 -0.0%	1.80	US$376
2016-07-27	2016-07-26	S Sale	Canaan VII LP Large shareholder	20,380 -0.9% 1.81 US$36,888	20,380 -0.9%	1.81	US$36,888
2016-07-26	2016-07-25	S Sale	Canaan VII LP Large shareholder	137,617 -5.9% 1.86 US$255,968	137,617 -5.9%	1.86	US$255,968
2016-07-26	2016-07-22	S Sale	Canaan VII LP Large shareholder	133,133 -5.4% 1.94 US$258,278	133,133 -5.4%	1.94	US$258,278
2016-02-11	2015-11-06	B Purchase	Cashman Christopher Michael President and CEO Executive Director	3,561 +3.2% 5.61 US$19,977	3,561 +3.2%	5.61	US$19,977
2015-04-23	2015-04-21	PlS Planned sale	3.7 Farfel Gail M Chief Clinical Dev & Reg Offic Officer	30,000 -100.0% 9.48 US$284,511	30,000 -100.0%	9.48	US$284,511
2014-08-07	2014-08-05	B Purchase	1.6 Mehra Anand Non-Executive Director Large shareholder	12,528 +81.0% 8.00 US$100,224	12,528 +81.0%	8.00	US$100,224
2014-08-07	2014-08-05	B Purchase	1.6 Mehra Anand Non-Executive Director Large shareholder	13,367 +5.9% 8.00 US$106,936	13,367 +5.9%	8.00	US$106,936
2014-08-07	2014-08-05	B Purchase	1.6 Mehra Anand Non-Executive Director Large shareholder	724,788 +63.9% 8.00 US$5,798,304	724,788 +63.9%	8.00	US$5,798,304
2014-08-07	2014-08-05	B Purchase	Domain Partners VI, L.P. Large shareholder	419,744 +20.4% 8.00 US$3,357,952	419,744 +20.4%	8.00	US$3,357,952
2014-08-06	2014-08-05	B Purchase	0.9 Bloch Stephen M Non-Executive Director	625,000 +34.0% 8.00 US$5,000,000	625,000 +34.0%	8.00	US$5,000,000
2014-08-06	2014-08-05	B Purchase	Canaan VII L P Non-Executive Director Large shareholder	625,000 +34.0% 8.00 US$5,000,000	625,000 +34.0%	8.00	US$5,000,000